- Human Biospecimens
- For Researchers
- For Biospecimen Contributors
- For Patients
The iSpecimen Marketplace®provides researchers with unprecedented technology, enabling precision sourcing of hematopoietic stem and immune cell products from expansive range of partners and donors worldwide
LEXINGTON, Mass., Sept. 24, 2019 — Devoted to supporting life science researchers who urgently pursue breakthroughs, iSpecimen today announced it has partnered with new providers of diseased and healthy hematologic tissue to offer one of the industry’s largest, most integrated networks of donors and collection sites available while addressing proliferating demand for hematopoietic stem and immune cell products.
Now, researchers can readily access cells with highly specific characteristics through the iSpecimen Marketplace, an online platform that increases access to human biospecimens from specific patients and healthy donors that can provide them.
iSpecimen continues to expand its partner network around the world, enabling researchers to efficiently procure bone marrow aspirate, peripheral blood mononuclear cells (normal and mobilized), and whole blood—all with corresponding donor profile/clinical data from healthy and diseased donors. Researchers today increasingly use these types of tissue and cell products in their work to develop stem cell therapies, immunotherapies, vaccines, diagnostics, new treatments for infectious and autoimmune diseases, and in cell-based assays to advance drug discovery and preclinical development.
Precision orders are simple, centralized and efficient
Using the iSpecimen Marketplace, researchers gain centralized, single-source access to a vast and growing population of healthy donors and patients (e.g., solid and liquid tumors, autoimmune, and numerous other diseases) with hematopoietic and immune cell phenotypes that match their particular research study criteria. Moreover, the Specimen Marketplace enables researchers to conveniently select from a comprehensive list of donor attributes, specify exclusion criteria, request a quote, and order banked or prospectively collected specimens online. By centralizing specimen procurement through the Marketplace, researchers can save precious time and human resources via a single source of procurement, order management, contracting, compliance and data access.
Unparalleled online selection, customization, compliance and order management experiences
iSpecimen also announced today it has upgraded the iSpecimen Marketplace experience for hematopoietic and immune cell customers, enabling a uniquely convenient and customizable online product selection experience. Now, researchers can easily refine their specimen selections involving numerous parameters such as HLA type (low and high resolution), blood type, body mass index, ethnicity, race, age, and gender. The iSpecimen Marketplace also offers the industry’s most comprehensive donor screening capability, permitting researchers to select the required scope of infectious disease testing such as CMV, hepatitis (B&C), HIV, West Nile Virus, syphilis, Chagas, and more.
The iSpecimen Marketplace incorporates a range of unique order management features into the hematopoietic and immune cell procurement experience, allowing researchers to centrally manage multiple quotes, orders, shipments, and invoices across a large partner network. Customers and partners can expect to see ongoing enhancements to the iSpecimen Marketplace, designed to continuously increase biospecimen access and improve key aspects of the biospecimen procurement journey.
As with any human biospecimen collection, iSpecimen ensures that cells are collected in accordance with U.S. Health and Human Services regulations as well as HIPAA guidelines. Biospecimens are also collected under iSpecimen’s IRB protocol with informed consent or under partners’ IRB/IEC protocols with informed consent, both of which have been reviewed and approved by iSpecimen’s compliance team.
“Hematopoietic stem and immune cells are used in some of the newest and most exciting medical science occurring today,” said Wayne Vaz, Vice President of Growth and Corporate Development.There is a clear market trend towards increasing supply chain efficiency while maintaining a high level of regulatory compliance, data integrity, product selection, speed, and scalability. With the iSpecimen Marketplace, everything is in one place online, streamlining the procurement of specimens much like popular websites do for flights, cars and hotels.”
Headquartered in Lexington, MA, iSpecimen is the marketplace for human biospecimens, providing researchers with the specimens they need from the patients they want. The privately held company has developed the iSpecimen Marketplace, an online platform connecting healthcare organizations that have access to patients and specimens with the scientists who need them. Proprietary cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. Researchers easily and compliantly gain access to specimens to drive scientific discovery. Partner sites gain an opportunity to contribute to biomedical discovery as well as their bottom line. Ultimately, healthcare advances for all. For more information about iSpecimen, please visit iSpecimen.com.